Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Germinal Center B-cell Type (GCB)”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Testing effectiveness (Phase 2)Study completedNCT00931918
What this trial is testing

Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients

Who this might be right for
Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL)
Millennium Pharmaceuticals, Inc. 206
Large-scale testing (Phase 3)UnknownNCT03018626
What this trial is testing

R-ACVBP and DA-EPOCH-R in Patients With Non-GCB DLBCL

Who this might be right for
Lymphoma, Large B-Cell, Diffuse
Nanfang Hospital, Southern Medical University 402
Early research (Phase 1)Study completedNCT01705847
What this trial is testing

A Phase 1b Study Evaluating GS-9820 in Subjects With Lymphoid Malignancies

Who this might be right for
Lymphoid Malignancies
Gilead Sciences 39
Testing effectiveness (Phase 2)WithdrawnNCT01415765
What this trial is testing

MLN4924 Compared With MLN4924 Plus Chemotherapy for Large B-cell Lymphoma

Who this might be right for
Lymphoma, Diffuse Large-Cell B-cellDiffuse, Large B-cell LymphomaLymphoma, Diffuse Large-Cell+1 more
National Cancer Institute (NCI)
Early research (Phase 1)Looking for participantsNCT07691606
What this trial is testing

ARC-02 in B-cell NHL

Who this might be right for
B-cell Non Hodgkin Lymphoma
Taiho Oncology, Inc. 140
Early research (Phase 1)Ended earlyNCT04933617
What this trial is testing

Copanlisib With Dose-Adjusted EPOCH-R in Relapsed and Refractory Burkitt Lymphoma and Other High-Grade B-cell Lymphomas

Who this might be right for
Burkitt LymphomaHigh-grade B-cell LymphomaT-cell/Histocyte-rich Large B-cell Lymphoma+2 more
National Cancer Institute (NCI) 8
Testing effectiveness (Phase 2)UnknownNCT06530511
What this trial is testing

Polatuzumab, Rituximab and Orelabrutinib Combination Regimen (PRO) in the Treatment of Elderly Frail Patients with Treatment-naive Non-GCB DLBCL

Who this might be right for
Diffuse Large B Cell Lymphoma
Affiliated Hospital of Nantong University 30
Early research (Phase 1)Active Not RecruitingNCT06667687
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
AbbVie 21
Large-scale testing (Phase 3)Active Not RecruitingNCT04529772
What this trial is testing

A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)

Who this might be right for
Diffuse Large B-Cell Lymphoma
Acerta Pharma BV 611
Testing effectiveness (Phase 2)UnknownNCT05422066
What this trial is testing

Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma

Who this might be right for
DLBCL Germinal Center B-Cell Type
Li Zhiming 50
Early research (Phase 1)Ended earlyNCT03558750
What this trial is testing

Rituximab, Lenalidomide, and Nivolumab in Treating Participants With Relapsed or Refractory Non-Germinal Center Type Diffuse Large B Cell Lymphoma or Primary Central Nervous System Lymphoma

Who this might be right for
Recurrent Central Nervous System LymphomaRecurrent Diffuse Large B-Cell LymphomaRefractory Central Nervous System Lymphoma+1 more
Vanderbilt-Ingram Cancer Center 6
Early research (Phase 1)Looking for participantsNCT05780034
What this trial is testing

AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

Who this might be right for
Relapsed/Refractory B-cell Malignancies
Accutar Biotechnology Inc 60